Literature DB >> 22988035

The thymic niche does not limit development of the naturally diverse population of mouse regulatory T lymphocytes.

Paola Romagnoli1, James Dooley, Genevieve Enault, Rita Vicente, Bernard Malissen, Adrian Liston, Joost P M van Meerwijk.   

Abstract

Thymus-derived CD4(+)Foxp3(+) regulatory T lymphocytes (Tregs) play a central role in the suppression of immune responses to self-antigens and thus avoid autoimmune disorders. It remains unclear if the specialized thymic niche controls the number of differentiating Tregs. We investigated development of murine Tregs from precursors expressing the naturally very large repertoire of TCRs. By analyzing their developmental kinetics, we observed that differentiating Tregs dwell in the thymus ∼1 d longer than their conventional T cell counterparts. By generating hematopoietic chimeras with very low proportions of trackable precursors, we could follow individual waves of developing T cells in the thymus. We observed strongly increased proportions of Tregs at the end of the waves, confirming that these cells are the last to leave the thymus. To assess whether the thymic niche limits Treg development, we generated hematopoietic chimeras in which very few T cell precursors could develop. The substantial increase in the proportion of Tregs we found in these mice suggested a limiting role of the thymic niche; however, this increase was accounted for entirely by the prolonged thymic dwell time of Tregs. We conclude that, when precursors express a naturally diverse TCR repertoire, the thymic niche does not limit differentiation of Tregs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988035     DOI: 10.4049/jimmunol.1201564

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors.

Authors:  Nicolas Thiault; Julie Darrigues; Véronique Adoue; Marine Gros; Bénédicte Binet; Corine Perals; Bertrand Leobon; Nicolas Fazilleau; Olivier P Joffre; Ellen A Robey; Joost P M van Meerwijk; Paola Romagnoli
Journal:  Nat Immunol       Date:  2015-05-04       Impact factor: 25.606

Review 2.  Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs.

Authors:  Kesley Attridge; Lucy S K Walker
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

3.  MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.

Authors:  Vani Lakshminarayanan; Nitin T Supekar; Jie Wei; Dustin B McCurry; Amylou C Dueck; Heidi E Kosiorek; Priyanka P Trivedi; Judy M Bradley; Cathy S Madsen; Latha B Pathangey; Dominique B Hoelzinger; Margreet A Wolfert; Geert-Jan Boons; Peter A Cohen; Sandra J Gendler
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.